<DOC>
	<DOCNO>NCT00902928</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety various dos YM150 ( experimental drug ) compare enoxaparin prevention venous thromboembolism patient undergo elective hip replacement surgery .</brief_summary>
	<brief_title>A Study Evaluating Efficacy Safety YM150 Compared Enoxaparin Subjects Undergoing Hip Replacement Surgery</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Darexaban</mesh_term>
	<criteria>Subject schedule elective hip replacement surgery Subject active bleeding condition associate increase risk bleeding Subject major trauma surgery within 3 month plan hip replacement surgery require major surgery invasive procedure potential uncontrolled bleeding study Subject MI stroke within 3 month plan hip replacement surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Elective hip replacement surgery</keyword>
	<keyword>Factor Xa</keyword>
	<keyword>Venous Thromboembolism</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>Anticoagulants</keyword>
	<keyword>Prevention</keyword>
	<keyword>YM150</keyword>
</DOC>